AAAAAA
Results:
1-10
|
Results: 10
Authors:
von Mehren, M
Arlen, P
Gulley, J
Rogatko, A
Cooper, HS
Meropol, NJ
Alpaugh, RK
Davey, M
McLaughlin, S
Beard, MT
Tsang, KY
Schlom, J
Weiner, LM
Citation: M. Von Mehren et al., The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma, CLIN CANC R, 7(5), 2001, pp. 1181-1191
Authors:
Chao, C
Al-Saleem, T
Brooks, JJ
Rogatko, A
Kraybill, WG
Eisenberg, B
Citation: C. Chao et al., Vascular endothelial growth factor and soft tissue sarcomas: Tumor expression correlates with grade, ANN SURG O, 8(3), 2001, pp. 260-267
Authors:
Schilder, RJ
Gallo, JM
Millenson, MM
Bookman, MA
Weiner, LM
Rogatko, A
Rogers, B
Padavic-Shallers, K
Boente, M
Rosenblum, N
Adams, AL
Ciccotto, S
Ozols, RF
Citation: Rj. Schilder et al., Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, andtopotecan with peripheral-blood stem-cell support as front-line therapy, J CL ONCOL, 19(4), 2001, pp. 1183-1194
Authors:
Babb, JS
Rogatko, A
Citation: Js. Babb et A. Rogatko, Patient specific dosing in a cancer phase I clinical trial, STAT MED, 20(14), 2001, pp. 2079-2090
Authors:
Haas, N
Roth, B
Garay, C
Yeslow, G
Entmacher, M
Weinstein, A
Rogatko, A
Babb, J
Minnitti, C
Flinker, D
Gillon, T
Hudes, G
Citation: N. Haas et al., Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer, UROLOGY, 58(1), 2001, pp. 59-64
Authors:
von Mehren, M
Arlen, P
Tsang, KY
Rogatko, A
Meropol, N
Cooper, HS
Davey, M
McLaughlin, S
Schlom, J
Weiner, LM
Citation: M. Von Mehren et al., Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas, CLIN CANC R, 6(6), 2000, pp. 2219-2228
Authors:
Schilder, RJ
Goldberg, M
Millenson, MM
Movsas, B
Rogatko, A
Rogers, B
Langer, CJ
Citation: Rj. Schilder et al., Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung, LUNG CANC, 27(1), 2000, pp. 37-45
Authors:
Daly, M
Farmer, J
Harrop-Stein, C
Montgomery, S
Itzen, M
Costalas, JW
Rogatko, A
Miller, S
Balshem, A
Gillespie, D
Citation: M. Daly et al., Exploring family relationships in cancer risk counseling using the genogram, CANC EPID B, 8(4), 1999, pp. 393-398
Authors:
Zekri, ARN
Bahnassi, AA
Bove, B
Huang, YJ
Russo, IH
Rogatko, A
Shaarawy, S
Shawki, OA
Hamza, MR
Omer, S
Khaled, HM
Russo, J
Citation: Arn. Zekri et al., Allelic instability as a predictor of survival in Egyptian breast cancer patients, INT J ONCOL, 15(4), 1999, pp. 757-767
Authors:
Rogatko, A
Babb, J
Jordan, H
Zacks, S
Citation: A. Rogatko et al., Constructing meiotic maps with known error probability, GENET EPID, 16(3), 1999, pp. 274-289
Risultati:
1-10
|